Dec. 17, 2025
Biotechnology in the FY 2026 NDAA: Strategic Implications — and Recommendations — for Joint Force Readiness
The newly released FY 26 NDAA places explicit emphasis upon the increasing involvement of biotechnology in US military missions. As 2025 comes to a close, and we look ahead to the new year, Dr. James Giordano, Director of the CDTFW, offers a view to why biotechnology is — and will be ever more — intrinsic and important to national defense and offers a set of recommendations for fortifying Joint Force engagement in the biotechnological domain.